Sensitive Detection of Cardiac Biomarkers Using a Magnetic Microbead Immunoassay.

To achieve improved sensitivity in cardiac biomarker detection, a batch incubation magnetic microbead immunoassay was developed and tested on three separate human protein targets: myoglobin, heart-type fatty acid binding protein, and cardiac troponin I. A sandwich immunoassay was performed in a simple micro-centrifuge tube allowing full dispersal of the solid capture surface during incubations. Following magnetic bead capture and wash steps, samples were analyzed in the presence of a manipulated magnetic field utilizing a modified microscope slide and fluorescent inverted microscope to collect video data files. Analysis of the video data allowed for the quantitation of myoglobin, heart-type fatty acid binding protein and cardiac troponin I to levels of 360 aM, 67 fM, and 42 fM, respectively. Compared to the previous detection limit of 50 pM for myoglobin, this offers a five-fold improvement in sensitivity. This improvement in sensitivity and incorporation of additional markers, along with the small sample volumes required, suggest the potential of this platform for incorporation as a detection method in a total sample analysis device enabling multiplexed detection for the analysis of clinical samples.

[1]  R. Vasan,et al.  Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations , 2006, Circulation.

[2]  Young Ki Hahn,et al.  Versatile immunoassays based on isomagnetophoresis. , 2011, Lab on a chip.

[3]  Juan Peng,et al.  Fluorescent immunosensor based on CuS nanoparticles for sensitive detection of cancer biomarker. , 2014, The Analyst.

[4]  R. Renneberg,et al.  Human heart-type fatty acid-binding protein for on-site diagnosis of early acute myocardial infarction. , 2009, International journal of cardiology.

[5]  Kim E. Sapsford,et al.  Evaluation of Optical Detection Platforms for Multiplexed Detection of Proteins and the Need for Point-of-Care Biosensors for Clinical Use , 2014, Sensors.

[6]  Prasun Mahanti,et al.  Improved detectability and signal strength for rotating phase fluorescence immunoassays through image processing. , 2011, The Analyst.

[7]  J. Niazi,et al.  Biosensors for cardiac biomarkers detection: A review , 2012 .

[8]  K. Chien,et al.  Prognostic relevance of plasma heart-type fatty acid binding protein after out-of-hospital cardiac arrest. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[9]  S. Takagi,et al.  Biomarker panel of cardiac and skeletal muscle troponins, fatty acid binding protein 3 and myosin light chain 3 for the accurate diagnosis of cardiotoxicity and musculoskeletal toxicity in rats. , 2012, Toxicology.

[10]  L. A. Currie,et al.  LIMITS FOR QUALITATIVE DETECTION AND QUANTITATIVE DETERMINATION. APPLICATION TO RADIOCHEMISTRY. , 1968 .

[11]  Mary Jo Kurth,et al.  Diagnostic accuracy of heart-type fatty acid-binding protein for the early diagnosis of acute myocardial infarction. , 2012, The American journal of emergency medicine.

[12]  H. Naruse,et al.  Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. , 1997, Clinical chemistry.

[13]  Kenji Inoue,et al.  Heart fatty acid-binding protein offers similar diagnostic performance to high-sensitivity troponin T in emergency room patients presenting with chest pain. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[14]  Christine F Woolley,et al.  Recent developments in emerging microimmunoassays. , 2013, Bioanalysis.

[15]  P. Goswami,et al.  Heart type fatty acid binding protein: structure, function and biosensing applications for early detection of myocardial infarction. , 2013, Biosensors & bioelectronics.

[16]  Hiroshi Handa,et al.  Magnetically promoted rapid immunoreactions using functionalized fluorescent magnetic beads: a proof of principle. , 2014, Clinical chemistry.

[17]  Andrey V Lisitsa,et al.  Highly sensitive detection of human cardiac myoglobin using a reverse sandwich immunoassay with a gold nanoparticle-enhanced surface plasmon resonance biosensor. , 2013, Analytica chimica acta.

[18]  John Tercier,et al.  Resuscitation , 2004, The Lancet.

[19]  S. Kharb.  Toxicology , 1936 .

[20]  Prasun Mahanti,et al.  Demonstration of sandwich and competitive modulated supraparticle fluoroimmunoassay applied to cardiac protein biomarker myoglobin. , 2009, The Analyst.

[21]  Yan Peng,et al.  The Application of CdTe/CdS in the Detection of Carcinoembryonic Antigen by Fluorescence Polarization Immunoassay , 2012, Journal of Fluorescence.

[22]  Peter Oefner,et al.  BIOANALYSIS , 2008, Electrophoresis.

[23]  Dejian Zhou,et al.  Magnetic particle-based ultrasensitive biosensors for diagnostics , 2012, Expert review of molecular diagnostics.

[24]  A Roda,et al.  Gravitational field-flow fractionation integrated with chemiluminescence detection for a self-standing point-of-care compact device in bioanalysis. , 2013, The Analyst.

[25]  H. Fujii.  [Fatty acid-binding protein]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.

[26]  E. Dufour-Gergam,et al.  A new controlled concept of immune-sensing platform for specific detection of Alzheimer's biomarkers. , 2013, Biosensors & bioelectronics.

[27]  Xiaoli Zhang,et al.  Ultrasensitive immunoassay based on anodic near-infrared electrochemiluminescence from dual-stabilizer-capped CdTe nanocrystals. , 2012, Analytical chemistry.

[28]  Anne-Laure Gassner,et al.  Total serum IgE quantification by microfluidic ELISA using magnetic beads , 2012, Analytical and Bioanalytical Chemistry.

[29]  Menno W J Prins,et al.  One-step homogeneous magnetic nanoparticle immunoassay for biomarker detection directly in blood plasma. , 2012, ACS nano.

[30]  Min Park,et al.  FACS-based immunoassay of troponin-I using E. coli cells with autodisplayed Z-domains , 2014 .

[31]  K. Mizuno,et al.  Heart-type fatty acid-binding protein is a novel prognostic marker in patients with essential hypertension. , 2014, International journal of cardiology.

[32]  E. G. Codding.  Lock-in amplifier based on a synchronously clocked transversal filter , 1979 .

[33]  Jianping Zhang,et al.  An immunoassay in which magnetic beads act both as collectors and sensitive amplifiers for detecting antigens in a microfluidic chip (MFC)–quartz crystal microbalance (QCM) system , 2011 .

[34]  Yong Duk Han,et al.  A fluoro-microbead guiding chip for simple and quantifiable immunoassay of cardiac troponin I (cTnI). , 2011, Biosensors & bioelectronics.

[35]  Charles S Henry,et al.  Detection of cardiac biomarkers using micellar electrokinetic chromatography and a cleavable tag immunoassay. , 2007, Analytical chemistry.

[36]  R. Body,et al.  A FABP-ulous 'rule out' strategy? Heart fatty acid binding protein and troponin for rapid exclusion of acute myocardial infarction. , 2011, Resuscitation.

[37]  P. Brambilla,et al.  Verification of an immunoturbidimetric assay for heart-type fatty acid-binding protein (H-FABP) on a clinical chemistry platform and establishment of the upper reference limit. , 2014, Clinical biochemistry.

[38]  H. S. Wolff,et al.  iRun: Horizontal and Vertical Shape of a Region-Based Graph Compression , 2022, Sensors.

[39]  R. Renneberg,et al.  Added value of H-FABP as a plasma biomarker for the early evaluation of suspected acute coronary syndrome , 2014 .

[40]  Mark A Hayes,et al.  Detection of FITC-cortisol via modulated supraparticle lighthouses. , 2006, Analytical chemistry.

[41]  Feng Yan,et al.  Triple signal amplification of graphene film, polybead carried gold nanoparticles as tracing tag and silver deposition for ultrasensitive electrochemical immunosensing. , 2012, Analytical chemistry.

[42]  Simon G. A. Brown,et al.  Serial multiple biomarkers in the assessment of suspected acute coronary syndrome: multiple infarct markers in chest pain (MIMIC) study , 2012, Emergency Medicine Journal.

[43]  A. Wear.  CIRCULATION , 1964, The Lancet.